| Health / Medical Topics |
Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12
A radioimmunoconjugate comprised of the monoclonal antibody AHN-12 conjugated to the radioisotope yttrium 90 with potential radioimmunotherapeutic activity. Yttrium Y 90 monoclonal antibody AHN-12 binds to the tyrosine phosphatase CD45, expressed on the surface of normal and malignant hematopoietic cells. After binding and internalization by CD45-expressing tumor cells, this agent may deliver a cytotoxic dose of beta radiation. (NCI Thesaurus)
YOU MAY ALSO LIKE
A radioimmunoconjugate consisting of the murine IgG1 anti-CD19 monoclonal antibody (MoAb) BU12 labeled with the beta-emitting radioisotope yttrium Y 90 with radioisotopic…
A radioactive form of the rare metal yttrium that is used in radiation therapy to treat some types of tumors. Yttrium Y…
A murine monoclonal antibody directed against the CD5 antigen and labeled with Yttrium-90, a beta-emitting radioisotope. CD5 is a type-I transmembrane glycoprotein…
A metal of the rare earth group of elements. A radioactive form of yttrium may be attached to a monoclonal antibody or…
Human YTHDF2 wild-type allele is located in the vicinity of 1p35 and is approximately 33 kb in length. This allele, which encodes…
This gene may be involved in both signaling and humoral immunity.
